Caris Life Sciences, Inc. (CAI)
NASDAQ·Healthcare·Biotechnology
$17.66
-4.31%
Mkt Cap $5.79B
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (7 analysts)
$28.75
Range $21.00 – $38.00
Implied Upside
+62.8%
Consensus $28.75 vs current $17.66
NASDAQ·Healthcare·Biotechnology
$17.66
-4.31%
Mkt Cap $5.79B
Buy
4
Hold
2
Sell
0
Price Target (7 analysts)
$28.75
Range $21.00 – $38.00
+62.8%
Consensus $28.75 vs current $17.66